Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Stemgenics

Stemgenics
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$445K LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a biotechnology company for skin treatment. The company offers regeneration of a variety of tissues of the human body to convert mature cells into personalized stem cells.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
  • 454 North 34th Street
  • Suite 100
  • Seattle, WA 98103
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Stemgenics’s full profile, request a free trial.

Stemgenics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 12-Jul-2018 $445K 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 29-Dec-2015 00.00 00.00 000.00 Completed Startup
2. Angel (individual) 03-Jan-2014 $1.1M $1.1M Completed Generating Revenue
1. Grant 28-Jun-2012 $150K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Stemgenics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B2a 000,000 00.00 00.00 00 00.00 0.000
Series B2d 0,000,000 00.00 00.00 00 00.00 00
Series B2c 0,000,000 00.00 00.00 00 00.00 00
Series B2b 000,000 00.00 00.00 00 00.00 00
Series B 000,000 00.00 00.00 00 00.00 0.000
Series A 2,566,655 $0.43 $0.43 1x $0.43 25.56%
Seed 2,310,000 $0.03 $0.03 1x $0.03 23%
To view this company’s complete Cap Table, request access »

Stemgenics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Science Foundation Government 000 0000 000000 0

Stemgenics Executive Team (3)

Name Title Board
Seat
Contact
Info
Frederick Hagen Ph.D Chief Executive Officer
Andranik Aprikyan Ph.D Co-Founder, Chief Scientific Officer, Executive Vice President and Board Member
Mushegh Hovhannisyan Executive Officer and Board Member

Stemgenics Board Members (1)

Name Representing Role Since Contact
Info
Mushegh Hovhannisyan Stemgenics Executive Officer and Board Member 000 0000